15 years ago we were told to use a red dot stimuli. My how times have changed. It seems to me that a full threshold maybe excessive and inaccurate. Patient reliability tends to trail off on the longer threshold tests. Has there been any macula VF studies on plaquenil patients? I'm curious to see if it really matters. I also thought plaquenil is more macula toxic than anywhere else in the eye. I'm not trying to create controversy, I'm just curious. Warm Regards, David Clark, COA Territory Manager / US Dealer Partners Topcon Medical Systems 111 Bauer Drive Oakland, NJ 07436 Dclark@xxxxxxxxxx Customer service 866-922-6278 Cell: 551-579-1062 Sent from my iPhone > On Oct 10, 2013, at 4:12 PM, "Curtis, Rhonda" <Curtis@xxxxxxxxxxxxxxxx> wrote: > > Bless you for all the techs out there who have ever done a full threshold > 10-2. > > Rhonda > > From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On > Behalf Of CPMC Ophthalmic Diagnostic Center > Sent: Thursday, October 10, 2013 3:06 PM > To: 'optimal@xxxxxxxxxxxxx' > Subject: [optimal] Re: From Denice re Marmor Protocol Plaquenil Screening > > Rhonda > > See small print in Ryan’s message. 10-2 SITA Standard About 4 minutes > > Denice Barsness, CRA, COMT, ROUB, CDOS, FOPS > Ophthalmic Diagnostic Center > CPMC Department of Ophthalmology > 2100 Webster Street Suite 212 > San Francisco CA 94115 > (415) 600-3937 FAX (415) 600-6563 > > From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On > Behalf Of Curtis, Rhonda > Sent: Thursday, October 10, 2013 12:59 PM > To: 'optimal@xxxxxxxxxxxxx' > Subject: [optimal] Re: From Denice re Marmor Protocol Plaquenil Screening > > Please, please be a white target used with a standard program – it takes > FOREVER to do the full threshold testing. > > Rhonda > > From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On > Behalf Of CPMC Ophthalmic Diagnostic Center > Sent: Thursday, October 10, 2013 2:37 PM > To: 'optimal@xxxxxxxxxxxxx' > Cc: Soboleva, Marina > Subject: [optimal] From Denice re Marmor Protocol Plaquenil Screening > > Can’t argue with that final weigh in.!!! Thanks Ryan, Thanks Optimal! > > Ryan, off optimal, can you contact me? I’d like your eMail and to chat. > > Thanks > > Denice Barsness, CRA, COMT, ROUB, CDOS, FOPS > Ophthalmic Diagnostic Center > CPMC Department of Ophthalmology > 2100 Webster Street Suite 212 > San Francisco CA 94115 > (415) 600-3937 FAX (415) 600-6563 > > From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On > Behalf Of Nelson, Ryan > Sent: Thursday, October 10, 2013 10:16 AM > To: optimal@xxxxxxxxxxxxx > Subject: [optimal] Re: From Denice re Marmor Protocol Plaquenil Screening > > All, > > I spoke with Dr. Marmor earlier this morning. He stated he uses the WHITE > target, 10-2 SITA with the Pattern Deviation Plot. Hope this helps. > > > <image001.jpg> > > > > From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On > Behalf Of Michael R. Turano, Jr. > Sent: Thursday, October 10, 2013 7:34 AM > To: optimal@xxxxxxxxxxxxx > Subject: [optimal] Re: From Denice re Marmor Protocol Plaquenil Screening > > 10-2 white is what the AAO paper states. > > > > Mike > __ > > Michael Turano > > c. 917.826.9506 > f. 917.591.1841 > e. turano@xxxxxxxxx > > > On Wed, Oct 9, 2013 at 5:16 PM, CPMC Ophthalmic Diagnostic Center > <cpmceyelab@xxxxxxxxxxxxxxxx> wrote: > The Marmor protocols for Plaquenil screening > > © 2011 by the American Academy of Ophthalmology ISSN 0161-6420/11/$–see front > matter 415 > Published by Elsevier Inc. doi:10.1016/j.ophtha.2010.11.017 > > > > Do not indicate if 10-2 VF should be white or red target. Does anyone out > there know for sure? > > > Denice > > Denice Barsness, CRA, COMT, ROUB, CDOS, FOPS > Ophthalmic Diagnostic Center > CPMC Department of Ophthalmology > 2100 Webster Street Suite 212 > San Francisco CA 94115 > (415) 600-3937 FAX (415) 600-6563 > > > > > The materials in this email are private and may contain Protected Health > Information. If you are not the intended recipient, be advised that any > unauthorized use, disclosure, copying, distribution or the taking of any > action in reliance on the contents of this information is strictly > prohibited. If you have received this email in error, please immediately > notify the sender via telephone or return email. >